Laddar populära aktier...
Researchers in China studying IRLAB’s lead asset, mesdopetam (IRL790) in a preclinical model for lev...
STENOCARE announced on June 17th that the company is planning an expansion into Canada together with...
The announcement of the updated DFS for Dannemora showed, as expected, higher CAPEX and OPEX compare...
Redeye leaves a comment following Magle’s announcement of an acquisition of pK Biotech ApS and its s...
Redeye comments on Lifecare after the announcement that its rights issue was oversubscribed, reinfor...
Redeye initiates coverage of Coegin Pharma, a hub and spoke biotech company with a diverse array of ...
VEF är investmentbolaget som ger en unik möjlighet till att få exponering mot snabbväxande Fintech-b...
Ovzon-3 has reached its orbital position (5 months after launch) We expect orders picking up in H2.
We initiate coverage of Solwers, a company that acts as a growth platform for the built environment ...
Redeye in this note provides our first impressions on Acconeer’s CEO change that was announced yeste...
Redeye comments on recent news from Apple about its intention to open up its ecosystem to third-part...
Redeye initiates coverage of WntResearch, a Swedish biotechnology company specialised in oncology.
Med ett nytt godkännande i Danmark för en THC/CBD medicinsk cannabisolja har Stenocare återtagit pos...
CMS’ NTAP recommendation is positive, and we can expect a final decision by August, followed by a go...
Aptahem är ett bioteknikbolag som utvecklar ett läkemedel som har potential att definiera om behandl...
